A detailed history of Klp Kapitalforvaltning As transactions in Pharvaris N.V. stock. As of the latest transaction made, Klp Kapitalforvaltning As holds 5,800 shares of PHVS stock, worth $100,746. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,800
Holding current value
$100,746
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

BUY
$17.87 - $25.01 $103,646 - $145,058
5,800 New
5,800 $111,000

Others Institutions Holding PHVS

About Pharvaris N.V.


  • Ticker PHVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,766,000
  • Market Cap $587M
  • Description
  • Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, r...
More about PHVS
Track This Portfolio

Track Klp Kapitalforvaltning As Portfolio

Follow Klp Kapitalforvaltning As and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Klp Kapitalforvaltning As, based on Form 13F filings with the SEC.

News

Stay updated on Klp Kapitalforvaltning As with notifications on news.